Clavulanate Potassium



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 59.7%
Bronchopulmonary Aspergillosis 14.9%
Aplasia 6.0%
Ill-defined Disorder 3.0%
Induction Of Anaesthesia 3.0%
Prophylaxis 3.0%
Pseudomonas Infection 3.0%
Septic Shock 3.0%
Anaesthesia 1.5%
Antibiotic Prophylaxis 1.5%
Surgery 1.5%
Face Oedema 12.5%
Gravitational Oedema 12.5%
Hyperbilirubinaemia 12.5%
Oedema Peripheral 12.5%
Pulse Absent 12.5%
Respiratory Tract Haemorrhage 12.5%
Thrombocytopenia 12.5%
Urogenital Haemorrhage 12.5%
Secondary
Product Used For Unknown Indication 33.2%
Bronchopulmonary Aspergillosis 11.9%
Drug Use For Unknown Indication 6.6%
Hypertension 5.8%
Prophylaxis 5.3%
Aspergillosis 4.4%
Infection 4.4%
Pain 3.5%
Abscess 2.7%
Acute Myeloid Leukaemia 2.7%
Pruritus 2.7%
Tooth Infection 2.7%
Vulvovaginal Mycotic Infection 2.7%
Urinary Tract Infection 2.2%
Atrial Fibrillation 1.8%
Bronchopneumopathy 1.8%
Toe Amputation 1.8%
Anaesthesia 1.3%
Bronchitis 1.3%
Lung Consolidation 1.3%
Cholestasis 10.0%
Drug Interaction 10.0%
Immunosuppressant Drug Level Decreased 10.0%
Renal Failure Acute 10.0%
Drug Hypersensitivity 5.0%
Drug Rash With Eosinophilia And Systemic Symptoms 5.0%
Hypersensitivity 5.0%
Impetigo 5.0%
Necrotising Ulcerative Gingivostomatitis 5.0%
Somnolence 5.0%
Tachypnoea 5.0%
Tremor 5.0%
Anaphylactic Shock 2.5%
Anxiety 2.5%
Hepatic Enzyme Increased 2.5%
Hepatitis 2.5%
Hepatocellular Injury 2.5%
Jaundice 2.5%
Maternal Drugs Affecting Foetus 2.5%
Myocardial Infarction 2.5%
Concomitant
Drug Use For Unknown Indication 18.4%
Analgesic Therapy 13.3%
Prophylaxis 9.6%
Product Used For Unknown Indication 8.3%
Diabetes Mellitus 7.2%
Hypertension 6.4%
Breast Cancer 5.9%
Multiple Myeloma 4.8%
Prostate Cancer 4.0%
Pneumonia 2.9%
Immunosuppression 2.7%
Non-small Cell Lung Cancer 2.7%
Pyrexia 2.4%
Metastases To Bone 2.1%
Breast Cancer Recurrent 1.6%
Horner's Syndrome 1.6%
Multiple Sclerosis 1.6%
Otitis Media 1.6%
Renal Transplant 1.6%
Asthma 1.3%
Wound Closure 47.7%
Pulmonary Embolism 6.3%
Pneumonia 5.4%
Rectal Haemorrhage 4.5%
Liver Function Test Abnormal 3.6%
Sepsis 3.6%
Sudden Death 3.6%
Thrombophlebitis 2.7%
Viral Infection 2.7%
Appendicitis 1.8%
Death 1.8%
Drug Exposure During Pregnancy 1.8%
Face Oedema 1.8%
Hypersensitivity 1.8%
Nausea 1.8%
Progressive Multifocal Leukoencephalopathy 1.8%
Pulmonary Haemorrhage 1.8%
Respiratory Distress 1.8%
Rhabdomyolysis 1.8%
Spinal Osteoarthritis 1.8%
Interacting
Product Used For Unknown Indication 71.4%
Muscle Spasticity 9.5%
Prophylaxis 9.5%
Respiratory Tract Infection 4.8%
Sedation 4.8%
Haemorrhage 50.0%
Hypertransaminasaemia 50.0%